148 related articles for article (PubMed ID: 2349736)
1. Long-term morbidity of cyclosporine with corticosteroid-free maintenance immunosuppression in cardiac transplantation.
Moore CK; Bristow MR; Renlund DG; Rasmussen LG; O'Connell JB
Transplant Proc; 1990 Jun; 22(3 Suppl 1):25-9. PubMed ID: 2349736
[No Abstract] [Full Text] [Related]
2. Long-term effects of cyclosporine-based immunosuppression in cardiac transplantation: the Loyola experience.
Costanzo-Nordin MR; Grady KL; Johnson MR; Winters GL; Ventura HO; Pifarré R
Transplant Proc; 1990 Jun; 22(3 Suppl 1):6-11. PubMed ID: 2349737
[No Abstract] [Full Text] [Related]
3. Hypercholesterolemia after heart transplantation: amelioration by corticosteroid-free maintenance immunosuppression.
Renlund DG; Bristow MR; Crandall BG; Burton NA; Doty DB; Karwande SV; Gay WA; Jones KW; Hegewald MG; Hagan ME
J Heart Transplant; 1989; 8(3):214-9; discussion 219-20. PubMed ID: 2661771
[TBL] [Abstract][Full Text] [Related]
4. Long-term effects of cyclosporine in cardiac transplantation.
Miller LW; Pennington DG; McBride LR
Transplant Proc; 1990 Jun; 22(3 Suppl 1):15-20. PubMed ID: 2349734
[No Abstract] [Full Text] [Related]
5. Renal function and blood pressure in heart transplant recipients treated with cyclosporine.
Rottembourg J; Mattei MF; Cabrol A; Leger P; Aupetit B; Beaufils H; Gluckman JC; Pavie A; Gandjbakhch I; Cabrol C
J Heart Transplant; 1985; 4(4):404-8. PubMed ID: 3916515
[TBL] [Abstract][Full Text] [Related]
6. Feasibility of discontinuation of corticosteroid maintenance therapy in heart transplantation.
Renlund DG; O'Connell JB; Gilbert EM; Watson FS; Bristow MR
J Heart Transplant; 1987; 6(2):71-8. PubMed ID: 3305832
[TBL] [Abstract][Full Text] [Related]
7. Monitoring of cyclosporine by serial posttransplant pharmacokinetic studies in renal transplant patients.
Awni WM; Heim-Duthoy K; Kasiske BL
Transplant Proc; 1990 Jun; 22(3):1343-4. PubMed ID: 2349693
[No Abstract] [Full Text] [Related]
8. Long-term follow-up of cyclosporine-treated cardiac transplant recipients.
Radovancevic B; Birovljev S; Frazier OH; Duncan JM; Bennink W; Sweeney MS; McAllister HA; Burnett CM; Vega JD; Lonquist JL
Transplant Proc; 1990 Jun; 22(3 Suppl 1):21-4. PubMed ID: 2349735
[No Abstract] [Full Text] [Related]
9. Optimal results in cadaveric renal transplantation with low-dose cyclosporine and steroids combined with prophylactic anti-lymphocyte globulin.
Fries D; Hiesse C; Charpentier B; Cantarovich M; Lantz O; Benoit G
Transplant Proc; 1988 Oct; 20(5 Suppl 6):23-5. PubMed ID: 3051581
[No Abstract] [Full Text] [Related]
10. Efficacy and safety of constant-rate intravenous cyclosporine infusion immediately after heart transplantation.
Schroeder TJ; Myre SA; Melvin DB; Van der Bel-Kahn J; Stephens GW; Collins JA; Wolf RK; Brown LL; Pesce AJ; First MR
J Heart Transplant; 1989; 8(1):5-10. PubMed ID: 2647932
[TBL] [Abstract][Full Text] [Related]
11. Amelioration of weight gain after heart transplantation by corticosteroid-free maintenance immunosuppression. UTAH Cardiac Transplant Program.
Hagan ME; Holland CS; Herrick CM; Rasmussen LG
J Heart Transplant; 1990; 9(4):382-4. PubMed ID: 2398433
[TBL] [Abstract][Full Text] [Related]
12. [Renal function in the immediate postoperative period after heart transplantation using very low initial doses of cyclosporin A].
Cladellas M; Sánchez JM; Abadal ML; Ballester M; Obrador D; Amengual MJ; Quintana E; Net A; Cámara ML; Padró JM
Rev Esp Cardiol; 1987; 40 Suppl 2():70-3. PubMed ID: 3331810
[No Abstract] [Full Text] [Related]
13. Effects of low-dose cyclosporine A on toxicity and rejection in cardiac transplantation.
Spratt P; Esmore D; Baron D; Shanahan MX; Farnsworth AE; Chang VP
Transplant Proc; 1987 Apr; 19(2):2847-50. PubMed ID: 3551225
[TBL] [Abstract][Full Text] [Related]
14. Clinical correlations of cyclosporine HPLC and FPIA levels in renal transplant recipients.
Sridhar N; Schroeder TJ; Pesce AJ; First MR
Transplant Proc; 1990 Jun; 22(3):1257-9. PubMed ID: 2190387
[No Abstract] [Full Text] [Related]
15. Cyclosporine: an immunosuppressive panacea?
Copeland JG; Emery RW; Levinson MM; Icenogle TB; Riley JE; McAleer MJ; Copeland JA; Dietz R
J Thorac Cardiovasc Surg; 1986 Jan; 91(1):26-39. PubMed ID: 3079849
[TBL] [Abstract][Full Text] [Related]
16. Management of cyclosporine toxicity by reduced dosage and azathioprine.
Griffith BP; Hardesty RL; Lee A; Trento A; Thompson ME; Shapiro AP; Bahnson HT
J Heart Transplant; 1985; 4(4):410-3. PubMed ID: 3916516
[TBL] [Abstract][Full Text] [Related]
17. Effectiveness of minimal dosage cyclosporine in limiting toxicity and rejection.
Spratt P; Esmore D; Baron D; Shanahan MX; Farnsworth AE; Chang VP
J Heart Transplant; 1986; 5(1):8-12. PubMed ID: 3302158
[TBL] [Abstract][Full Text] [Related]
18. Avoidance of perioperative renal toxicity by a modified immunosuppression protocol.
Kormos RL; Trento A; Hardesty RL; Griffith BP; Thompson M; Bahnson HT
Transplant Proc; 1987 Feb; 19(1 Pt 3):2525-6. PubMed ID: 3274555
[No Abstract] [Full Text] [Related]
19. Arterial hypertension in heart transplant recipients treated with triple-drug immunosuppressive therapy.
Olivari MT; Antolick A; Ring WS
J Heart Transplant; 1989; 8(1):34-9. PubMed ID: 2647929
[TBL] [Abstract][Full Text] [Related]
20. Heart transplantation: limitations and perspectives.
Struck E; Hagl S; Meisner H; Sebening F
Z Kardiol; 1985; 74 Suppl 6():59-63. PubMed ID: 3913181
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
